The Technical Analyst
Select Language :
MacroGenics Inc [MGNX]

Exchange: Nasdaq Global Select Sector: Healthcare Industry: Biotechnology

MacroGenics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

MacroGenics Inc is listed at the NASDAQ Exchange

3.39% $3.05

Last updated: 3 jul 2022 - 19:07

TimeZone: America/New_York


FUNDAMENTALS
MarketCap: 187.07 mill
EPS: -3.56
P/E: 0.000
Earnings Date: Jul 27, 2022
SharesOutstanding: 61.33 mill
Avg Daily Volume: 1.172 mill
RATING 2022-07-01
B+
Neutral
RATINGDETAILS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Buy
P/E: Sell
Price To Book: Strong Buy
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenue
Gr.Profitn/an/a
Ebit
Asset
Debt
DISCOUNTED CASH FLOW VALUE
$5.10
(67.12%) $2.05
Date: 2022-07-03
True Range Average
+/- $0.317
( +/- 10.39%)
Range: 2.73 - 3.37
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-06-15 Karrels James Buy 40 000 Common Stock
2022-05-23 Heiden William K Buy 36 000 Stock Option (right to buy)
2022-05-19 Ferrante Karen Jean Buy 20 640 Stock Option (right to buy)
2022-05-19 Ferrante Karen Jean Buy 18 000 Stock Option (right to buy)
2022-05-19 Hurwitz Edward Buy 18 000 Stock Option (right to buy)
INSIDER POWER
88.33
Last 100 transactions
Buy: 4 051 419 | Sell: 290 743

Forecast: 16:00 - $3.05

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $3.05
Forecast 2: 16:00 - $3.05
Forecast 3: 16:00 - $3.05
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $3.05 (3.39% )
Volume 0.662 mill
Avg. Vol. 1.172 mill
% of Avg. Vol 56.45 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for MacroGenics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for MacroGenics Inc

RSI

Intraday RSI14 chart for MacroGenics Inc

Last 10 Buy & Sell Signals For MGNX

14 Signals | Accuracy: 21.43% | Accuracy Buy: 28.57% | Accuracy Sell: 14.29%

Avg return buy: -0.06 % | Avg return sell: 0.22 %

$1 invested is now $1.00 or -0.49% since 30-06-22

Date Signal @ Closed %
Jun 30 - 12:05sell$2.98$2.95 @ Jun 30 - 15:57-0.84%
Jun 30 - 12:02buy$2.99$2.98 @ Jun 30 - 12:05-0.34%
Jun 30 - 11:51sell$2.98$2.99 @ Jun 30 - 12:020.17%
Jun 30 - 11:48buy$2.99$2.98 @ Jun 30 - 11:51-0.33%
Jun 30 - 11:30sell$2.99$2.99 @ Jun 30 - 11:480.00%
Jun 30 - 11:11buy$3.00$2.99 @ Jun 30 - 11:30-0.33%
Jun 30 - 09:30sell$2.96$3.00 @ Jun 30 - 11:111.35%
Jun 30 - 09:29buy$3.02$2.96 @ Jun 30 - 09:30-1.99%
The Live Chart for MacroGenics Inc
Profile picture for
            MacroGenics Inc

MGNX

MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics for the treatment of cancer in the United States. Its pipeline of immuno-oncology product candidates includes Margetuximab, a monoclonal antibody, which is in Phase III clinical trial that targets HER2-expressing tumors, such as various breast and gastroesophageal cancers. The company is also developing Flotetuzumab, a DART molecule that recognizes CD123 and CD3 for treating acute myeloid leukemia; MGA012, an investigational monoclonal antibody targeting PD-1; MGD013, a monoclonal antibody that targets the PD-1 and lymphocyte-activation gene 3; MGD019, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; and Enoblituzumab, a monoclonal antibody that targets B7-H3. In addition, the company is developing combination of MGD009 and MGA012; MGC018, an antibody drug conjugate, which targets solid tumors expressing B7-H3; and MGD014, a DART molecule that targets envelope protein of human immunodeficiency virus infected cells and T cells. It has strategic collaborations with Incyte Corporation; Zai Lab Limited; and I-Mab Biopharma. MacroGenics, Inc. was founded in 2000 and is headquartered in Rockville, Maryland.

Last 10 Buy Signals
Date Signal @
GAMEUSDJul 3 - 19:050.0152
FCTUSDJul 3 - 19:040.277
CVCUSDJul 3 - 19:030.139
GBYTEUSDJul 3 - 19:0213.47
SNMUSDJul 3 - 19:020.0564
UBQUSDJul 3 - 19:020.0337
BTGUSDJul 3 - 18:5915.40
GNOUSDJul 3 - 18:58110.80
BNBUSDJul 3 - 18:58218.64
LTCUSDJul 3 - 18:5850.80

Stock Peers

Company Price Change
MGNX3.053.39%
COGT9.394.10%
GRCL5.10-7.27%
JYNT16.095.09%
KALV9.900.61%
LQDA4.24-2.75%
PRLD5.301.53%
VBIV0.808-0.01%
VMD5.430.93%
VTGN0.872-0.90%
ZTEK1.700-6.08%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.